Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Statement of Cash Flows [Abstract]
Net Income (Loss)	$ 68,845	$ 12,965
Adjustments to reconcile net income to net cash used in operating activities:
Provision for (recovery of) bad debts	493	(3,987)
Deferred tax (benefit) expense	(3,666)	14,539
Depreciation and amortization	20,587	20,487
Amortization of debt discount and issuance costs	2,160	3,004
Interest paid-in-kind	3,421	2,256
Equity based compensation	3,264	0
Contingent consideration	16,008	178
Warranty provision	633	244
Provision for inventory obsolescence	2,517	2,201
Changes in operating assets and liabilities
Accounts receivable	(22,340)	(63,241)
Inventories	48,992	(40,050)
Income tax receivables	(15,890)	8,445
Prepaid expenses and other	7,222	9,848
Accounts payable	(82,284)	33,064
Accounts payable - related party	(3,690)	438
Accrued expenses and other	4,644	(13,221)
Income tax payable	6,584	2,458
Deferred revenue	(284,000)	(1,148)
Net Cash Used in Operating Activities	(226,500)	(11,520)
Cash Flows Used in Investing Activities
Purchase of property, plant and equipment	(610)	(784)
Net Cash Used in Investing Activities	(610)	(784)
Cash Flows from Financing Activities
Proceeds from (payments on) revolving loan	32	(5,807)
Principal payments on term loan	(57,702)	(20,000)
Payments on related party loans	(45,558)	0
Deferred offering costs	(3,775)	0
Capital contribution	0	133
Net Cash Used in Financing Activities	(107,003)	(25,674)
Net Decrease in Cash and Restricted Cash	(334,113)	(37,978)
Cash and Restricted Cash, beginning of year	361,257	40,826
Cash and Restricted Cash, end of year	$ 27,144	$ 2,848